User contributions
Jump to navigation
Jump to search
- 02:54, 22 July 2020 diff hist +3,473 N An Effective Treatment for Coronavirus (COVID-19) Created page with "Category:Article Category:Covid19 {| class="infobox" width=200px |class="publication"|'''Publication''' |- |Title || <ul>[https://github.com/covidtrial/info/raw/master..."
- 02:49, 22 July 2020 diff hist -9 Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
- 02:45, 22 July 2020 diff hist -262 Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial current
- 02:43, 22 July 2020 diff hist +8 No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19 current
- 02:42, 22 July 2020 diff hist +104 No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
- 02:38, 22 July 2020 diff hist -232 No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19
- 02:36, 22 July 2020 diff hist +1 Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
- 02:36, 22 July 2020 diff hist -64 Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
- 02:36, 22 July 2020 diff hist -48 Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
- 02:35, 22 July 2020 diff hist -4 Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
- 02:35, 22 July 2020 diff hist -14 Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19
- 02:34, 22 July 2020 diff hist -1 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- 02:34, 22 July 2020 diff hist -4 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- 02:34, 22 July 2020 diff hist +91 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- 02:32, 22 July 2020 diff hist -5 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- 02:29, 22 July 2020 diff hist -64 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- 02:29, 22 July 2020 diff hist -86 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- 20:47, 21 July 2020 diff hist +59 About OmniJournal
- 18:24, 21 July 2020 diff hist -213 About OmniJournal
- 18:20, 21 July 2020 diff hist +564 About OmniJournal
- 05:36, 15 July 2020 diff hist -153 m Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19
- 05:01, 15 July 2020 diff hist +1 m COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study grammar
- 05:01, 15 July 2020 diff hist +1 m Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis grammar
- 05:00, 15 July 2020 diff hist +42 COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study
- 04:51, 15 July 2020 diff hist +42 Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- 19:48, 14 July 2020 diff hist +70 Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial
- 19:27, 14 July 2020 diff hist +1,498 N Hydroxychloroquine in patients with COVID-19: an open-label, randomized, controlled trial RCT of HCQ in China
- 18:15, 14 July 2020 diff hist +394 Template:Main page
- 18:13, 14 July 2020 diff hist +2,164 N COVID-19 Outpatients – Early Risk-Stratified Treatment with Zinc Plus Low Dose Hydroxychloroquine and Azithromycin: A Retrospective Case Series Study Zelenko study
- 18:07, 14 July 2020 diff hist +2,759 N Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis Raoult 3rd study
- 18:01, 14 July 2020 diff hist -5 COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study
- 17:57, 14 July 2020 diff hist +1,694 N COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study HCQ as potential ppx
- 16:51, 14 July 2020 diff hist +2,331 N Treatment Response to Hydroxychloroquine and Antibiotics for mild to moderate COVID-19: a retrospective cohort study from South Korea HCQ S Korea study for mild disease
- 15:39, 14 July 2020 diff hist +2,324 N Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Results of an Open-Label Non-Randomized Clinical Trial: Response to David Spencer (Elsevier) Created page with "{| class="infobox" width=200px |style="width:100%; font-size:24px;"|'''Publication''' |- |Title || <ul>[https://www.mediterranee-infection.com/wp-content/uploads/2020/07/Respo..."
- 15:16, 14 July 2020 diff hist +3,619 N Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19 Henry Ford study on HCQ
- 15:05, 14 July 2020 diff hist +2,758 N A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 Minnesota postexposure prophylaxis study of HCQ
- 14:34, 14 July 2020 diff hist +438 No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19 publication details
- 03:27, 14 July 2020 diff hist -64 Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France formatting
- 03:26, 14 July 2020 diff hist +2,125 N Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France Raoult second study on HCQ and AZ
- 03:13, 14 July 2020 diff hist +2,489 N Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Raoult first study on HCQ and AZ
- 19:10, 13 July 2020 diff hist -2 Template:Main page
- 14:26, 13 July 2020 diff hist +18,851 N Privacy policy Privacy Policy
- 14:26, 13 July 2020 diff hist +2,121 N Disclaimers Disclaimers current
- 14:24, 13 July 2020 diff hist +21,327 N Terms of Use Terms of Use
- 14:21, 13 July 2020 diff hist +10 Privacy Policy
- 13:51, 13 July 2020 diff hist +18,841 N Privacy Policy Privacy Policy
- 18:20, 6 July 2020 diff hist -1 Template:Main page
- 16:56, 6 July 2020 diff hist -120 Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
- 16:33, 26 June 2020 diff hist +5,344 N No clinical benefit from use of hydroxychloroquine in hospitalised patients with COVID-19 New article by James Todaro on Oxford's RECOVERY trial
- 07:07, 26 June 2020 diff hist +5 m Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis Section edit